Episode
Modernizing Clinical Trial Operations With Merck's Jennifer Sheller
- Podcast
- Business Of Biotech
- Published
- Dec 22, 2025
- Duration seconds
- 3339
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/business-of-biotech-123501/episodes/modernizing-clinical-trial-operations-with-merck-s-jennifer-sheller/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/business-of-biotech-123501/modernizing-clinical-trial-operations-with-merck-s-jennifer-sheller.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Jennifer Sheller, SVP and Head of Global Clinical Trial Operations at Merck talks about simplifying trial protocols and what she likes about Merck's hybrid functional service provider model for conducting trials in over 60 countries. Jennifer shares her experiences integrating Merck's acquisitions without breaking studies or losing people, using new technology to improve trial operations...